Skip to main content
Premium Trial:

Request an Annual Quote

ASCO's CancerLinQ Partners With Non-Profit CI4CC to Improve Disease Research

NEW YORK (GenomeWeb) – CancerLinQ, a subsidiary of the American Society of Clinical Oncology (ASCO), has partnered with the non-profit Cancer Informatics for Cancer Centers (CI4CC) to improve cancer research.

CancerLinQ was established to develop an eponymous health IT platform that would allow oncologists to access real-world patient care data from electronic health records, guide personalized cancer treatment decisions, and improve precision medicine research. It is based on SAP's Hana data-management and application platform. According to ASCO, a total of 58 oncology practices across the US have thus far joined CancerLinQ. As a result, the platform is now drawing on approximately 750,000 patient records nationwide 

Under the terms of the collaboration, CancerLinQ and CI4CC will establish and informatics advisory council for CancerLinQ comprised of leading experts from US cancer centers. CancerLinQ will also place a representative on CI4CC's leadership board.

"Improving the quality and value of cancer care for everyone through big data is a team effort, requiring the innovations and ideas from every facet of the health community," said CancerLinQ CEO Kevin Fitzpatrick. "By working with CI4CC, we will be able to leverage the invaluable knowledge and experience of the organization's leading informaticists and data scientists to help us enrich the data-laden capabilities" of the CancerLinQ platform.